IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
Zannikou M, Duffy JT, Levine RN, Seblani M, Liu Q, Presser A, Arrieta VA, Chen CJ, Sonabend AM, Horbinski CM, Lee-Chang C, Miska J, Lesniak MS, Gottschalk S, Balyasnikova IV.
Zannikou M, et al. Among authors: lesniak ms.
J Immunother Cancer. 2023 Feb;11(2):e006239. doi: 10.1136/jitc-2022-006239.
J Immunother Cancer. 2023.
PMID: 36759014
Free PMC article.